首页|舒肝宁联合多烯磷脂酰胆碱对非酒精性脂肪性肝病患者的临床疗效及安全性分析

舒肝宁联合多烯磷脂酰胆碱对非酒精性脂肪性肝病患者的临床疗效及安全性分析

Clinical efficacy and safety analysis of Shuganning combined with Polyene Phosphatidyl Choline in patients with non-alcoholic fatty liver disease

扫码查看
目的 探讨舒肝宁联合多烯磷脂酰胆碱对非酒精性脂肪性肝病(NAFLD)患者的临床疗效及安全性分析.方法 选取2017年1月至2022年10月于九江市柴桑区人民医院住院的84例NAFLD患者作为研究对象,依据随机数字表法分为对照组和观察组,每组各42例.对照组给予常规护肝和多烯磷脂酰胆碱治疗,观察组在对照组基础上加用舒肝宁治疗.比较两组患者体征指标、肝功能、脂代谢、血清炎症因子水平、细胞免疫指标.结果 观察组体重指数(BMI)、腰围低于对照组,肝/脾CT比值高于对照组,差异有统计学意义(P<0.05);观察组丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素(TBil)低于对照组,总蛋白(TP)高于对照组,差异有统计学意义(P<0.05).观察组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)低于对照组,高密度脂蛋白胆固醇(HDL-C)高于对照组,差异有统计学意义(P<0.05);观察组肿瘤坏死因子-α(TNF-α)、血清铁蛋白(SF)、Toll样受体-4(TLR-4)、转化生长因子-β1(TGF-β1)水平低于对照组;观察组CD8+水平低于对照组,CD3+、CD4+水平,CD4+/CD8+高于对照组,差异有统计学意义(P<0.05);观察组总有效率高于对照组,差异有统计学意义(P<0.05).两组患者的不良反应总发生率比较,差异无统计学意义(P>0.05).结论 舒肝宁联合多烯磷脂酰胆碱可以改善NAFLD患者肝功能、调节脂代谢水平,降低炎症刺激,增强机体免疫力,安全性较好.
Objective To explore the clinical efficacy and safety analysis of Shuganning combined with Polyene Phos-phatidyl Choline in patients with non-alcoholic fatty liver disease(NAFLD).Methods A total of 84 patients with NAFLD hospitalized in Chaisang District People's Hospital of Jiujiang City from January 2017 to October 2022 were selected as the study objects,and they were divided into control group and observation group according to random number table method,with 42 cases in each group.The control group was treated with routine liver protection and Polyene Phosphatidyl Choline,and the observation group was treated with Shuganning on the basis of the control group.The physical signs,liver function,lipid metabolism,serum level of inflammatory factors and cellular immunity were compared between the two groups.Results The body mass index(BMI)and waistline of observation group were lower than those of control group,liver/spleen CT ratio was higher than that of control group,the differences were statistically significant(P<0.05).Alanine transaminase(ALT),aspartate transaminase(AST)and total bilirubin(TBil)in observation group were lower than those in control group,and total protein(TP)was higher than that of control group,the differences were statistically significant(P<0.05).Total cholesterol(TC),triglyceride(TG)and low density lipoprotein cholesterol(LDL-C)in observation group were lower than those in control group,and high density lipoprotein cholesterol(HDL-C)was higher than that in control group,the differences were statisti-cally significant(P<0.05).The levels of tumor necrosis factor-α(TNF-α),serum ferritin(SF),Toll-like receptor 4(TLR-4)and transforming growth factor-β 1(TGF-β 1)in observation group were lower than those in control group;CD8+level in observation group was lower than that in control group,level of CD3+and CD4+,CD4+/CD8+were higher than those in control group,the differences were statisti-cally significant(P<0.05).The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the total adverse reaction rate between the two groups(P>0.05).Conclusion Shuganning combined with Polyene Phosphatidyl Choline can improve liver function,regulate lipid metabolism,reduce inflammatory stimulation and enhance immunity in NAFLD patients with good safety.

ShuganningPolyene Phosphatidyl CholineNon-alcoholic fatty liver diseaseCellular immunity

梅继柱、刘斌

展开 >

江西省九江市柴桑区人民医院消化内科,江西九江 332100

舒肝宁 多烯磷脂酰胆碱 非酒精性脂肪性肝病 细胞免疫

中国肝炎防治基金会资助项目江西省中医药管理局科技计划项目

TQGB20200135SZYYB20233159

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(22)